S&T Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

S&T Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.48K	Hold	5	–	–	﹤0.01%	385
2026 Q1	$2.23K	Buy	5 +1	+25%	+$466	﹤0.01%	359
2025 Q4	$1.81K	Hold	4	–	–	﹤0.01%	351
2025 Q3	$1.57K	Buy	4 +1	+33%	+$418	﹤0.01%	421
2025 Q2	$1.34K	Hold	3	–	–	﹤0.01%	415
2025 Q1	$1.45K	Buy	+3	New	+$1.4K	﹤0.01%	334

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

S&T Bank's VRTX Position: Q2 2026 in Review

S&T Bank held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 5 shares worth $2.48K. The position accounts for ﹤0.01% of the portfolio, ranked #385.

S&T Bank first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

S&T Bank held 5 shares of Vertex Pharmaceuticals worth $2.48K as of Q2 2026.
S&T Bank left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up ﹤0.01% of S&T Bank's portfolio in Q2 2026, its #385 holding.
S&T Bank first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.